Ute Jucknischke - Concepedia

Concepedia

Author

Ute Jucknischke

Roche (Switzerland)

Also Known As

U Jucknischke, U. Jucknischke, Ute Jucknischke

12

Publications

1.6K

Citations

7

H-Index

29

Concepts

All Affiliations

Roche (Switzerland)Roche Pharma AG (Germany)

UJ

About

Ute Jucknischke is an author at Roche (Switzerland) specializing in medicine, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.5K
2	Cell Biology	3	3	125
3	Engineering	1	1	44
4	Natural Sciences	1	1	54
5	Biomolecular Engineering	1	1	44

Ute Jucknischke

×

7

Publications

1.6K

Citations

7

H-Index

	Year	Citations
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy Carola H. Ries, Michael A. Cannarile, Sabine Hoves, Cancer Cell Cancer TherapyTumor BiologyTumor-associated MacrophagesTumor ImmunologyCancer Immunosurveillance	2014	1.3K
A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity Raffaella Castoldi, Veronika Ecker, Laura Wiehle, Oncogene	2013	61
Mutants of Protein Kinase A that Mimic the ATP-binding Site of Protein Kinase B (AKT) M. Gaßel, C.B. Breitenlechner, Petra Rüger, Journal of Molecular Biology Protein Kinase ASignal TransductionMolecular PhysiologyProtein FunctionNatural Sciences	2003	54
Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties Raffaella Castoldi, Ute Jucknischke, Leon P. Pradel, Protein Engineering Design and Selection EngineeringImmunologyImmunotherapeuticsImmunotherapyTumor Biology	2012	44
Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains Yvonne Kienast, Ute Jucknischke, Stefan Scheiblich, Journal of Biological Chemistry	2015	41
TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations Raffaella Castoldi, Jürgen Schanzer, Christian Panke, Protein Engineering Design and Selection Oncogenic AgentReceptor Tyrosine KinaseImmunologyTumor Growth InhibitionCancer Growth	2016	27
Impact of selective anti‐BMP9 treatment on tumor cells and tumor angiogenesis Verena Brand, Christian H.K. Lehmann, Christian Umkehrer, Molecular Oncology	2016	15

Page 1